HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Veronika Kovács-Haász Selected Research

177Lu-DOTA-rituximab

10/2020Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Veronika Kovács-Haász Research Topics

Disease

1Lymphoma (Lymphomas)
10/2020
1Neoplasms (Cancer)
10/2020

Drug/Important Bio-Agent (IBA)

11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2020
1DOTA-NHSIBA
10/2020
1177Lu-DOTA-rituximabIBA
10/2020
1Chelating AgentsIBA
10/2020

Therapy/Procedure

1Radioimmunotherapy
10/2020